Autopsy report · NCT00123903
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
Cause of deathNo reason given
Life of this trial
- Ran for about 10 months before it stopped.
- 1,220 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- GlaxoSmithKline
- Sponsor type
- Industry
- Conditions
- Heart Failure, Congestive and Microalbuminuria
- Interventions
- metoprolol xl; carvedilol MR; lisinopril
- Participants
- 1,220
- Sites
- 94
- Countries
- Canada, Puerto Rico, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.